Načítá se...
Irreversible electroporation and the pancreas: What we know and where we are going?
Pancreatic adenocarcinoma continues to have a poor prognosis with 1 and 5 years survival rates of 27% and 6% respectively. The gold standard of treatment is resection, however, only approximately 10% of patients present with resectable disease. Approximately 40% of patients present with disease that...
Uloženo v:
| Vydáno v: | World J Gastrointest Surg |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Inc
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4550840/ https://ncbi.nlm.nih.gov/pubmed/26328033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4240/wjgs.v7.i8.138 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|